Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Often overlooked in the debates around health care spending or discussions of where to focus drug research funding, diabetes ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

Scientists discover that a compound in broccoli helps lower blood sugar, offering a new approach to diabetes prevention. See how it works.

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...